Skip to main content
NVDA-2.21%AAPL+3.23%GOOGL+0.69%MSFT-0.05%AMZN-0.34%TSM-1.33%SPCX-0.03%AVGO-0.71%META-1.38%TSLA-1.05%SKHY-4.40%MU-4.51%BRK-B0.00%LLY+0.20%JPM-0.47%WMT-0.02%AMD-3.07%V-0.09%XOM+0.70%ASMLa-1.66%JNJ-0.17%INTC-5.02%MA-0.44%0700.HK-1.94%1398.HK+0.79%ORCL-4.69%ABBV+1.24%BAC-0.28%CSCO-1.37%CVX-0.36%COST-0.07%KO+0.54%LRCX-5.02%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.58%UNH-0.95%HSBA.L-1.30%DELL-4.12%PG+0.24%MS-1.02%GE-0.58%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.11%HD-1.73%0939.HK+1.66%GS-1.19%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.37%GBPJPY-1.27%EURJPY-1.25%USDJPY-1.24%CADJPY-1.21%NZDCHF-1.06%USDZAR+1.03%USDSEK+0.94%USDNOK+0.90%EURZAR+0.85%AUDNZD+0.79%GBPZAR+0.76%EURSEK+0.75%EURNOK+0.72%USDTHB+0.69%AUDCAD-0.69%AUDDKK-0.66%AUDUSD-0.64%EURAUD+0.63%CHFSEK+0.60%USDMXN+0.59%GBPAUD+0.59%CHFNOK+0.57%AUDSGD-0.56%USDPLN+0.44%NZDSGD-0.42%GBPTRY+0.41%NOKJPY-0.40%CADCHF+0.39%USDCHF+0.38%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%AUDCHF-0.26%EURPLN+0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.08%EURCNH-0.06%AUDNOK+0.06%PLNJPY+0.06%EURCZK-0.05%CHFSGD-0.05%EURGBP+0.04%EURCAD-0.04%USDCOP-0.04%GBPUSD-0.03%USDCAD-0.02%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.19%UKOIL+5.78%USOIL+5.62%XAGUSD-5.44%GAGUSD-5.44%HG1-4.88%XAUUSD-1.74%GAUUSD-1.74%XNGUSD+1.54%COTTON0.00%SUGAR0.00%S10.00%BTCUSD-1.32%ETHUSD+0.06%USDTUSD-0.02%XRPUSD-2.73%SOLUSD-1.47%TRXUSDT+0.24%ZECUSDT-9.00%DOGEUSD-2.27%XMRUSDT+0.46%LINKUSD-1.23%XLMUSD-1.37%BCHUSDT-9.63%LTCUSD-1.63%UNIUSD-0.90%TONUSD+24.88%HBARUSDT-1.99%SUIUSD-4.06%TAOUSDT-5.37%AAVEUSD-1.98%DOTUSDT-1.56%ICPUSDT-0.36%ONDOUSDT-3.20%WLDUSDT-3.15%ATOMUSDT-2.87%ARBUSDT-0.50%JUPUSDT-3.39%INJUSDT-1.98%STXUSDT-4.53%FETUSDT-2.62%TIAUSDT-1.13%PYTHUSDT-1.05%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.55%WIFUSDT-4.89%OPUSDT-4.00%POLUSDT-4.48%IOTAUSDT-3.81%AXSUSDT-2.04%FARTCOINUSDT-2.74%EOSUSDT-2.66%DYDXUSDT-2.31%ORDIUSDT-0.73%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.21%AAPL+3.23%GOOGL+0.69%MSFT-0.05%AMZN-0.34%TSM-1.33%SPCX-0.03%AVGO-0.71%META-1.38%TSLA-1.05%SKHY-4.40%MU-4.51%BRK-B0.00%LLY+0.20%JPM-0.47%WMT-0.02%AMD-3.07%V-0.09%XOM+0.70%ASMLa-1.66%JNJ-0.17%INTC-5.02%MA-0.44%0700.HK-1.94%1398.HK+0.79%ORCL-4.69%ABBV+1.24%BAC-0.28%CSCO-1.37%CVX-0.36%COST-0.07%KO+0.54%LRCX-5.02%CAT-1.31%AP2d-1.55%0005.HK-0.78%AMAT-2.58%UNH-0.95%HSBA.L-1.30%DELL-4.12%PG+0.24%MS-1.02%GE-0.58%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.11%HD-1.73%0939.HK+1.66%GS-1.19%NZDJPY-2.63%AUDJPY-1.87%CHFJPY-1.61%NZDCAD-1.45%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.37%GBPJPY-1.27%EURJPY-1.25%USDJPY-1.24%CADJPY-1.21%NZDCHF-1.06%USDZAR+1.03%USDSEK+0.94%USDNOK+0.90%EURZAR+0.85%AUDNZD+0.79%GBPZAR+0.76%EURSEK+0.75%EURNOK+0.72%USDTHB+0.69%AUDCAD-0.69%AUDDKK-0.66%AUDUSD-0.64%EURAUD+0.63%CHFSEK+0.60%USDMXN+0.59%GBPAUD+0.59%CHFNOK+0.57%AUDSGD-0.56%USDPLN+0.44%NZDSGD-0.42%GBPTRY+0.41%NOKJPY-0.40%CADCHF+0.39%USDCHF+0.38%EURCHF+0.36%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.28%AUDCHF-0.26%EURPLN+0.26%SGDJPY+0.22%EURHKD-0.19%USDDKK+0.18%USDILS+0.16%NZDMXN-0.13%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.08%EURCNH-0.06%AUDNOK+0.06%PLNJPY+0.06%EURCZK-0.05%CHFSGD-0.05%EURGBP+0.04%EURCAD-0.04%USDCOP-0.04%GBPUSD-0.03%USDCAD-0.02%USDHKD+0.02%EURUSD-0.01%GBPSGD+0.01%EURDKK0.00%XPTUSD-6.19%UKOIL+5.78%USOIL+5.62%XAGUSD-5.44%GAGUSD-5.44%HG1-4.88%XAUUSD-1.74%GAUUSD-1.74%XNGUSD+1.54%COTTON0.00%SUGAR0.00%S10.00%BTCUSD-1.32%ETHUSD+0.06%USDTUSD-0.02%XRPUSD-2.73%SOLUSD-1.47%TRXUSDT+0.24%ZECUSDT-9.00%DOGEUSD-2.27%XMRUSDT+0.46%LINKUSD-1.23%XLMUSD-1.37%BCHUSDT-9.63%LTCUSD-1.63%UNIUSD-0.90%TONUSD+24.88%HBARUSDT-1.99%SUIUSD-4.06%TAOUSDT-5.37%AAVEUSD-1.98%DOTUSDT-1.56%ICPUSDT-0.36%ONDOUSDT-3.20%WLDUSDT-3.15%ATOMUSDT-2.87%ARBUSDT-0.50%JUPUSDT-3.39%INJUSDT-1.98%STXUSDT-4.53%FETUSDT-2.62%TIAUSDT-1.13%PYTHUSDT-1.05%SEIUSDT-6.02%IMXUSDT-3.85%GRTUSDT-3.55%WIFUSDT-4.89%OPUSDT-4.00%POLUSDT-4.48%IOTAUSDT-3.81%AXSUSDT-2.04%FARTCOINUSDT-2.74%EOSUSDT-2.66%DYDXUSDT-2.31%ORDIUSDT-0.73%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
OM

Omeros Corporation (OMER)

NASDAQ • Healthcare

$19.39
+$0.26 (+1.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$19.01
Previous Close$19.39
Day Range$18.93 - $19.55
Avg. Volume (3M)2.4M
Market Cap$1.3B
P/E Ratio10.2
52 Week Range
$3.94$19.65
Next EarningsIn 63 daysNov 12, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$28.5M100%
Gross Profitminus cost of goods$27.7M97%
Operating Incomeminus R&D and overhead$74K0%
Net Incomeminus taxes and the rest$13.2M46%

In plain terms: out of every $100 in revenue, Omeros Corporation keeps $46 as net profit.

Fundamentals & Financials

Revenue (TTM)
$38.4M
Net Income (TTM)
$124.8M
EPS (TTM)
$1.91
ROA (TTM)
43.52%
Current Ratio
1.95

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+670.9%Q1 2026$3.14
+40.0%Q2 2026-$0.24
+155.9%Q3 2026$0.15
Next

Nov 12

in 63 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Omeros Corporation

Omeros Corporation is an OMER-listed Biotechnology company on NASDAQ that develops small-molecule and protein-based therapies. The company focuses on inflammatory conditions, complement-mediated diseases, immune-related cancers, and addiction or compulsion disorders, and it is a drug developer founded in 1994 and based in Seattle, Washington.

Name
Omeros Corporation
CEO
Gregory A. Demopulos
Website
www.omeros.com
Industry
Healthcare
Year Founded
1994
Employees
175

Today's Snapshot

AI-generated

So far today, OMER is trading 4.6% lower at 18.50, in line with a weaker sector.

Trading Volume

Below 10d avg (1.3M)

840.4K

vs S&P 500 Today

Strong Underperformance

-3.98%

Updated: September 10, 2026 at 19:25 UTC

Technical Indicators

4 Buy3 Neutral1 Sell
OMER presents a constructive longer-term setup driven by a strong trend reading and heavy positive volume even though the price is under short-term pivots. ADX is firmly elevated, and OBV is strongly positive, signaling trend strength and accumulation, while MACD and momentum are flat-to-positive and RSI sits above neutral, supporting bullish bias. The stock trades above its 50–200 day averages but is marginally under short-term moving averages and the pivot/VWAP, suggesting near-term resistance. Technical takeaway: Buy — robust trend and volume support the bullish orientation despite short-term consolidation.
All signals
  • EMA (5 indicators)$11.94 - $18.77
    Buy
  • RSI (14)61.34
    Neutral
  • Stochastic %K (14, 3, 3)63.52
    Neutral
  • MACD Level (12, 26)1.38
    Neutral

Peers & Related Assets

FDMT4D Molecular Therapeutics, Inc.
$14.18-3.1%
FULCFulcrum Therapeutics, Inc.
$3.84+0.5%
ADCTADC Therapeutics S.A.
$1.22-6.2%
GOSSGossamer Bio, Inc.
$0.16-11.2%
RAPTRAPT Therapeutics, Inc.
LXRXLexicon Pharmaceuticals, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.